PLANO, TEXAS – April 11, 2022 – Integer Holdings Corporation (NYSE: ITGR), a leading
medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in
exhibiting at the MD&M West Exposition at the Anaheim Convention Center in Anaheim, Calif., from April 12-14,
2022.
During the event, attendees are invited to visit Integer at booth #2615 to learn more about the company’s
breadth and depth of innovative medical device manufacturing, design and development capabilities. This encompasses
expanded offerings as a result of the acquisition of Oscor in December 2021 and the acquisition of Aran Biomedical
this month.
“We take great pride in our capabilities and commitment to serving as a trusted and innovative partner to our
customers and their patients,” said Joel Becker, president of Integer’s Cardiac Rhythm Management and
Neuromodulation business.
“We are truly stronger together with the addition of Oscor and Aran Biomedical to the Integer team,” said
Payman Khales, President of Integer’s Cardio & Vascular business. “Our expanded capabilities not
only meet our customers’ evolving needs, but additionally enable them to get to market faster. We look forward
to showcasing this and more at MD&M West.”
Examples of how Integer can expedite time to market include:
- Finished Leads Capabilities: Integer’s proven end-to-end design, development and scalable
manufacturing solutions accelerate and optimize customers’ leads programs. This includes designing and
developing full lead systems and sub-assemblies, vertically integrated manufacturing as well as customizable
services to complement customers’ existing capabilities.
- Xcellion® Rechargeable Batteries: Integer’s new Xcellion®
Gen 3 Lithium Ion Fast Charge Rechargeable Batteries deliver leading performance for implantable pulse
generators (IPGs) and other medical devices. Xcellion® Gen 3 batteries reduce charging time by up
to 70 percent*, increase battery runtime by up to 30 percent* and retain 70 percent original capacity after
6,000+ full cycles.
In addition, examples of finished guiding sheaths ready for OEM branding include:
- Destino Reach: Wide range of deflectable sheaths specific to electrophysiology (EP)/transseptal
procedures in a variety of French sizes and lengths. Key features include bi-directional deflectable tip,
reinforced shaft for kink resistance, SureSealTM hemostatic valve, transseptal needle compatible,
soft atraumatic tip and distal flush holes.
- Destino Twist HTS: This peripheral and intracardiac sheath with a short handle deflectable
guiding sheath eliminates the need for brachial access and provides a stable platform to delivery catheters,
guidewires and stents. The primary application is aortic procedures used as a platform for branched endovascular
aneurysm repair (BEVAR), as well as EP use for placement of ultrasound catheters during left atrial appendage
(LAA) procedures.
MD&M West attendees can additionally learn more about differentiated, proprietary biomaterial technologies for
implantable cardiovascular devices to enable our customers’ innovation as a result of the addition of Aran
Biomedical to Integer. Visit Aran Biomedical at booth #1082.
Learn more about Integer at www.integer.net.
*Compared to Xcellion® Gen 2 technology
About Integer®
Integer Holdings Corporation (NYSE: ITGR) is one of the
largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular,
portable medical, advanced surgical and orthopedics markets. The company provides innovative, high-quality medical
technologies that enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche
applications in energy, military, and environmental markets. Greatbatch Medical®, Lake Region
Medical® and Electrochem® comprise the company’s brands. Additional information
is available at www.integer.net.
# # #